vs
Side-by-side financial comparison of Equity Residential (EQR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $781.9M, roughly 1.4× Equity Residential). Equity Residential runs the higher net margin — 48.9% vs -127.8%, a 176.7% gap on every dollar of revenue. On growth, Equity Residential posted the faster year-over-year revenue change (2.0% vs -2.5%). Over the past eight quarters, Equity Residential's revenue compounded faster (3.4% CAGR vs 1.3%).
Equity Residential is a United States–based publicly traded real estate investment trust that invests in apartments.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
EQR vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $781.9M | $1.1B |
| Net Profit | $382.1M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 50.6% | -116.0% |
| Net Margin | 48.9% | -127.8% |
| Revenue YoY | 2.0% | -2.5% |
| Net Profit YoY | -8.8% | -3093.9% |
| EPS (diluted) | $1.01 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $781.9M | $1.1B | ||
| Q3 25 | $782.4M | $1.0B | ||
| Q2 25 | $768.8M | $1.1B | ||
| Q1 25 | $760.8M | $1.0B | ||
| Q4 24 | $766.8M | $1.1B | ||
| Q3 24 | $748.3M | $1.1B | ||
| Q2 24 | $734.2M | $1.1B | ||
| Q1 24 | $730.8M | $1.1B |
| Q4 25 | $382.1M | $-1.4B | ||
| Q3 25 | $289.1M | $7.5M | ||
| Q2 25 | $192.4M | $-8.4M | ||
| Q1 25 | $256.6M | $-6.4M | ||
| Q4 24 | $419.1M | $-44.4M | ||
| Q3 24 | $143.4M | $-21.0M | ||
| Q2 24 | $177.5M | $-108.4M | ||
| Q1 24 | $295.8M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 50.6% | -116.0% | ||
| Q3 25 | 38.5% | 7.0% | ||
| Q2 25 | 26.6% | 4.3% | ||
| Q1 25 | 35.7% | 4.5% | ||
| Q4 24 | 57.2% | 10.0% | ||
| Q3 24 | 20.1% | 7.4% | ||
| Q2 24 | 25.3% | -2.5% | ||
| Q1 24 | 42.0% | -5.1% |
| Q4 25 | 48.9% | -127.8% | ||
| Q3 25 | 36.9% | 0.7% | ||
| Q2 25 | 25.0% | -0.8% | ||
| Q1 25 | 33.7% | -0.6% | ||
| Q4 24 | 54.7% | -3.9% | ||
| Q3 24 | 19.2% | -1.9% | ||
| Q2 24 | 24.2% | -10.2% | ||
| Q1 24 | 40.5% | 0.2% |
| Q4 25 | $1.01 | $-10.23 | ||
| Q3 25 | $0.76 | $0.05 | ||
| Q2 25 | $0.50 | $-0.06 | ||
| Q1 25 | $0.67 | $-0.05 | ||
| Q4 24 | $1.10 | $-0.32 | ||
| Q3 24 | $0.38 | $-0.15 | ||
| Q2 24 | $0.47 | $-0.79 | ||
| Q1 24 | $0.77 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $55.9M | — |
| Total DebtLower is stronger | $8.2B | — |
| Stockholders' EquityBook value | $11.0B | $2.9B |
| Total Assets | $20.7B | $8.5B |
| Debt / EquityLower = less leverage | 0.75× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.9M | — | ||
| Q3 25 | $93.1M | $432.1M | ||
| Q2 25 | $31.3M | $454.2M | ||
| Q1 25 | $39.8M | $409.9M | ||
| Q4 24 | $62.3M | $558.8M | ||
| Q3 24 | $28.6M | $1.5B | ||
| Q2 24 | $38.3M | $542.8M | ||
| Q1 24 | $44.5M | $658.5M |
| Q4 25 | $8.2B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.2B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $11.0B | $2.9B | ||
| Q3 25 | $11.1B | $4.4B | ||
| Q2 25 | $11.0B | $4.5B | ||
| Q1 25 | $11.0B | $4.4B | ||
| Q4 24 | $11.0B | $4.3B | ||
| Q3 24 | $10.9B | $4.6B | ||
| Q2 24 | $11.0B | $4.5B | ||
| Q1 24 | $11.1B | $4.7B |
| Q4 25 | $20.7B | $8.5B | ||
| Q3 25 | $21.1B | $10.1B | ||
| Q2 25 | $21.0B | $10.1B | ||
| Q1 25 | $20.6B | $9.8B | ||
| Q4 24 | $20.8B | $9.6B | ||
| Q3 24 | $20.9B | $11.2B | ||
| Q2 24 | $19.8B | $10.4B | ||
| Q1 24 | $19.9B | $10.6B |
| Q4 25 | 0.75× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $387.0M | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 1.01× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $387.0M | $175.4M | ||
| Q3 25 | $476.7M | $51.7M | ||
| Q2 25 | $359.5M | $75.9M | ||
| Q1 25 | $425.5M | $-64.5M | ||
| Q4 24 | $354.2M | $312.6M | ||
| Q3 24 | $401.4M | $42.2M | ||
| Q2 24 | $396.9M | $9.5M | ||
| Q1 24 | $421.0M | $-1.4M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $-18.9M | ||
| Q1 24 | — | $-26.5M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | -1.8% | ||
| Q1 24 | — | -2.4% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | 1.01× | — | ||
| Q3 25 | 1.65× | 6.89× | ||
| Q2 25 | 1.87× | — | ||
| Q1 25 | 1.66× | — | ||
| Q4 24 | 0.85× | — | ||
| Q3 24 | 2.80× | — | ||
| Q2 24 | 2.24× | — | ||
| Q1 24 | 1.42× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EQR
Segment breakdown not available.
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
